Workflow
RGA(RGA)
icon
Search documents
Reinsurance Group of America, Incorporated 2025 Q3 - Results - Earnings Call Presentation (NYSE:RGA) 2025-11-04
Seeking Alpha· 2025-11-04 23:07
Group 1 - The article does not provide any specific content related to a company or industry [1]
RGA(RGA) - 2025 Q3 - Quarterly Report
2025-10-31 16:49
Financial Performance - Total revenues for Q3 2025 reached $6,204 million, a 9.7% increase from $5,651 million in Q3 2024[10] - Net premiums for Q3 2025 were $4,280 million, down 2.5% from $4,391 million in Q3 2024[10] - Net investment income increased to $1,475 million in Q3 2025, compared to $1,188 million in Q3 2024, reflecting a 24.2% growth[10] - Net income for Q3 2025 was $255 million, up 61.6% from $158 million in Q3 2024[10] - Basic earnings per share for Q3 2025 were $3.85, compared to $2.37 in Q3 2024, representing a 62.5% increase[10] - Comprehensive income for Q3 2025 was $1,055 million, compared to $1,450 million in Q3 2024, reflecting a decrease of 27.2%[12] Assets and Liabilities - Total assets as of September 30, 2025, amounted to $152,003 million, up from $118,675 million at the end of 2024, a growth of 28.0%[8] - Total liabilities increased to $138,935 million as of September 30, 2025, compared to $107,769 million at the end of 2024, a rise of 28.9%[8] - The company reported total equity of $13,068 million as of September 30, 2025, up from $10,906 million at the end of 2024, a growth of 19.8%[8] Cash Flow and Investments - Total cash provided by operating activities for the nine months ended September 30, 2025, was $3,239 million, a decrease from $7,770 million in 2024[16] - Net cash used in investing activities for the nine months ended September 30, 2025, was $8,824 million, compared to $8,383 million in 2024[16] - The balance of cash and cash equivalents at the end of the period on September 30, 2025, was $4,625 million, down from $5,195 million at the end of September 2024[16] Shareholder Returns - Dividends to shareholders increased to $0.93 per share in Q3 2025 from $0.89 per share in Q3 2024[15] - The company repurchased 406,337 shares of common stock during the nine months ended September 30, 2025, with $425 million remaining under the share repurchase authorization[26] Future Policy Benefits - Future policy benefits rose to $66,389 million as of September 30, 2025, compared to $53,368 million at the end of 2024, an increase of 24.5%[8] - The liability for future policy benefits for the Traditional business increased by $183 million in Q3 2025, compared to a $39 million increase in Q3 2024, primarily due to updated mortality and lapse assumptions[33] Investment Performance - The company reported a total investment income of $4,280 million for the nine months ended September 30, 2025, compared to $3,359 million for the same period in 2024, reflecting a growth of 27.4%[81] - The total fixed maturity securities as of September 30, 2025, amounted to $45,788 million, with unrealized losses of $6,512 million[80] Segment Performance - The U.S. and Latin America segment generated revenues of $2,190 million, while the Europe, Middle East, and Africa segment contributed $1,070 million[164] - The segment revenues for U.S. and Latin America amounted to $6,701 million, while Europe, Middle East, and Africa contributed $1,985 million[166] Regulatory and Compliance - The company does not expect any material adverse effects from pending legal, regulatory, and governmental matters on its financial condition[151] - The company is required to maintain a consolidated stockholders' equity above $2.0 billion to avoid triggering certain provisions in the facility agreement[177] Accounting and Standards - The company anticipates adopting new accounting standards related to income taxes and disaggregation of income statement expenses by December 31, 2025, and December 31, 2027, respectively[180]
Reinsurance Group Q3 Earnings Top Estimates on Solid Investment Income
ZACKS· 2025-10-31 16:20
Core Insights - Reinsurance Group of America (RGA) reported third-quarter 2025 adjusted operating earnings of $6.37 per share, exceeding the Zacks Consensus Estimate by 9.8% and reflecting a 3.9% increase year over year [1][10] - The company's operating revenues reached $6.2 billion, surpassing estimates by 0.9% and showing an 8% year-over-year growth driven by higher net investment income and other revenues [2][10] Financial Performance - Net premiums totaled $4.3 billion, a decline of 2.5% year over year, while investment income rose 24% to $1.5 billion [3] - Total benefits and expenses increased by 8.2% year over year to $5.9 billion, attributed to higher claims, policy benefits, and operating expenses [4] Segment Performance - U.S. and Latin America segment reported a pre-tax adjusted operating income of $236 million, up 48.4% year over year, with the Traditional segment's income increasing by 72% to $136 million [5] - The Financial Solutions segment's pre-tax adjusted operating income rose 25% to $100 million, benefiting from the Equitable transaction [6] - Asia/Pacific segment's pre-tax adjusted operating income surged nearly threefold to $209 million, offsetting losses in EMEA [11] EMEA and Corporate Performance - EMEA segment experienced a pre-tax adjusted operating loss of $52 million, contrasting with a profit of $68 million in the previous year [8] - Corporate and Other segment reported a wider pre-tax adjusted operating loss of $58 million, primarily due to lower variable investment income and higher expenses [13] Financial Metrics - As of September 30, 2025, RGA's total assets amounted to $152 billion, a 26.4% increase year over year, with a book value per share of $158.67, up 6% [14] - The adjusted operating return on equity was 13.2%, a contraction of 60 basis points year over year [14] Capital Deployment - RGA deployed $1.7 billion into in-force block transactions, including $1.5 billion into Equitable Holdings, and repurchased shares worth $75 million [15] - A quarterly dividend of 93 cents was declared, to be paid on November 25, 2025 [15]
RGA(RGA) - 2025 Q3 - Earnings Call Transcript
2025-10-31 15:00
Financial Data and Key Metrics Changes - The company reported record operating EPS of $6.37 per share, exceeding expectations [4][13] - Pre-tax adjusted operating income was $534 million for the quarter, with an adjusted operating return on equity of 14.2% for the trailing 12 months [13][14] - Traditional business premium growth was 8.5% year-to-date on a constant currency basis, indicating strong momentum across regions [16][19] Business Line Data and Key Metrics Changes - The U.S. traditional business experienced modestly unfavorable claims experience, but overall results were supported by in-force management actions [18][19] - The Asia Pacific region showed strong traditional results, with significant growth in critical illness products and continued innovation [7][8] - EMEA results reflected favorable underwriting margins and successful transactions across various product lines [8][19] Market Data and Key Metrics Changes - The company deployed $2.4 billion of capital year-to-date, with $1.5 billion into the Equitable transaction and $900 million into over 20 other transactions globally [9][10] - The value of in-force business margins increased by 16% over the past three quarters, indicating strong new business momentum [11][24] Company Strategy and Development Direction - The company continues to focus on innovative underwriting and strategic partnerships, particularly in the U.S. and Asia [6][7] - The Equitable transaction is expected to contribute significantly to future earnings, with a projected pre-tax income of around $70 million for the full year [18][19] - The company aims to balance capital deployment into the business with returning capital to shareholders through dividends and share repurchases [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning in the right markets and the execution of effective strategies [12][24] - The company anticipates continued strong opportunities across geographies and business lines, supported by a robust capital position [24][25] Other Important Information - The company repurchased $75 million of common shares during the quarter, indicating a commitment to returning capital to shareholders [5][15] - The effective tax rate for the quarter was 19.6%, below the expected range, primarily due to the jurisdictional mix of earnings [15][16] Q&A Session Summary Question: U.S. claims activity in traditional - Management indicated that the negative claims experience was within normal volatility, with $30 million from individual life and $20 million from group business [28] Question: One-time items impacting U.S. premiums - A recapture of a treaty resulted in a positive impact of about $20 million, which affected the premium growth rate [29] Question: Impact of GLP-1 drugs on mortality assumptions - Management has not made material changes to assumptions but is confident that existing mortality improvement assumptions will be realized [32] Question: LDTI annual run rate increase - The annual run rate is expected to increase by $15 million next year, gradually ramping up to $25 million by 2040 [34] Question: Ruby Re's business activity - Ruby Re is focused on U.S. asset-intensive transactions, with a pipeline of transactions expected to be fully deployed by mid-2026 [38] Question: In-force actions opportunities - The company is on track with in-force actions, expecting about $50 million a year, with $45 million achieved year-to-date [42] Question: UK mortality trends - The company has increased expectations for future UK mortality, reflecting ongoing excess mortality in the population [52] Question: Equitable block accounting smoothing - Approximately 50% of the Equitable block is expected to benefit from accounting smoothing over time [55] Question: Group headwinds from medical claims - The group business is expected to be fully repriced by January 2026, with profitability anticipated thereafter [57] Question: Competitive positioning and risk appetite - Management emphasized that there has been no change in risk appetite or processes, maintaining a focus on exclusive transactions [60] Question: LDTI smoothing expectations - Management believes LDTI will provide smoothing benefits over time, although results may vary quarter by quarter [64] Question: Economic solvency opportunities in Japan - The company has seen increased activity in Japan, driven by co-insurance of blocks, and continues to pursue selective opportunities [70]
RGA(RGA) - 2025 Q3 - Earnings Call Presentation
2025-10-31 14:00
Financial Performance - Adjusted operating income, excluding notable items, was $6371 per diluted share[15] - Trailing twelve month adjusted operating ROE, excluding notable items, was 142%[15] - The company deployed approximately $17 billion of capital during the quarter into in-force block transactions, including $15 billion into the EQH transaction[15] Business Growth and Momentum - Traditional premium growth was 85% year-to-date on a constant currency basis[15] - Value of In-force Business Margins increased by $61 billion, or 162%, to $437 billion in the first nine months of the year[15] Capital Management - Estimated deployable capital is $34 billion[15] - Estimated excess capital totaled $23 billion[15] - The company repurchased $75 million of common shares[15] Investment Portfolio - Assets under management are approximately $132 billion[31] - Over 94% of fixed maturity securities are rated investment-grade[31] - The company experienced Q3 impairments and change in allowances of $35 million[35]
Reinsurance Group Of America Remains A 'Show Me Story'
Seeking Alpha· 2025-10-31 11:15
Group 1 - The Reinsurance Group of America (RGA) has underperformed in the past year, with a loss of approximately 11% in share value [1] - RGA is actively pursuing growth through significant deals, including partnerships with firms like Equitable [1]
Reinsurance Group (RGA) Tops Q3 Earnings and Revenue Estimates
ZACKS· 2025-10-30 22:56
Core Insights - Reinsurance Group (RGA) reported quarterly earnings of $6.37 per share, exceeding the Zacks Consensus Estimate of $5.8 per share, and showing an increase from $6.13 per share a year ago, resulting in an earnings surprise of +9.83% [1] - The company generated revenues of $6.19 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.95% and up from $5.73 billion year-over-year [2] - RGA's stock has underperformed the market, losing about 11.2% since the beginning of the year compared to the S&P 500's gain of 17.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $5.52 on revenues of $6.33 billion, while for the current fiscal year, the estimate is $21.77 on revenues of $23.46 billion [7] - The estimate revisions trend for RGA was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Insurance - Life Insurance industry, to which RGA belongs, is currently in the top 30% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Another company in the same industry, Brighthouse Financial (BHF), is expected to report quarterly earnings of $5.09 per share, reflecting a year-over-year change of +27.6% [9]
RGA(RGA) - 2025 Q3 - Quarterly Results
2025-10-30 20:17
Financial Performance - Net premiums for Q3 2025 were $4,280 million, a decrease of $111 million compared to Q2 2025 and a decline of $1,237 million year-to-date from $13,687 million in 2024[7]. - Net income available to RGA's shareholders increased to $253 million in Q3 2025, up from $180 million in Q2 2025, and up $150 million year-to-date compared to $569 million in 2024[7]. - Adjusted operating income for Q3 2025 was $310 million, slightly down from $315 million in Q2 2025, and down $5 million year-to-date from $1,008 million in 2024[7]. - Total revenues for the three months ended September 30, 2025, were $6,204 million, an increase of 9.9% compared to $5,651 million in the prior year[9]. - Year-to-date revenues reached $17,063 million, a slight increase of 1.2% compared to $16,866 million in the previous year[9]. - The company reported a year-to-date revenue of $1,188 million, which is $28 million higher than the same period last year[28]. - Total revenues for the three months ended September 30, 2025, were $956 million, an increase of $137 million or 16.7% compared to the prior quarter[44]. Shareholder Returns - Total returned to shareholders in Q3 2025 was $136 million, significantly higher than $59 million in Q2 2025, and up $84 million year-to-date from $170 million in 2024[7]. - Shareholders' dividends paid increased to $61 million in Q3 2025, up from $59 million in Q2 2025, and up $9 million year-to-date from $170 million in 2024[7]. - RGA, Inc. shareholders' equity reached $12,978 million as of September 30, 2025, up from $12,053 million at June 30, 2025, reflecting a 7.7% increase[96]. - Book value per share increased to $197.52 as of September 30, 2025, compared to $182.37 at June 30, 2025, a rise of 8.3%[97]. Investment Performance - Net investment income rose to $1,475 million, up 24.2% from $1,188 million in the same quarter last year[9]. - The company reported net investment income of $282 million for Q3 2025, an increase of $56 million compared to the same quarter last year[18]. - Total assets increased to $152.003 billion as of September 30, 2025, up from $120.258 billion a year earlier, representing a growth of 26.4%[15]. - Total investments rose to $127.604 billion as of September 30, 2025, compared to $98.236 billion a year ago, marking a 29.9% increase[15]. - The annualized investment yield for the three months ended September 30, 2025, was 4.73%, down 35 basis points from 5.08% in the prior year quarter[62]. Claims and Benefits - Adjusted claims and other policy benefits were $4,356 million, an increase of 5.8% from $4,116 million in the prior year[9]. - The company reported a total benefits and expenses of $5,884 million, which is a 8.2% increase compared to $5,437 million in the same quarter last year[9]. - The loss ratio for Q3 2025 was 91.5%, a slight improvement from 91.9% in Q2 2025, while the year-to-date loss ratio was 93.9%, up from 90.2% in the prior year[18]. - Adjusted claims and other policy benefits totaled $511 million, a decrease of 22% from $654 million in the same quarter last year[22]. - Total benefits and expenses amounted to $970 million, an increase of 47% compared to $923 million in the same quarter last year[22]. Segment Performance - Income before income taxes for U.S. and Latin America Traditional decreased to $123 million in Q3 2025 from $149 million in Q2 2025, a decline of 17.4%[84]. - Income before income taxes for Canada Traditional increased to $41 million in Q3 2025, compared to $32 million in Q2 2025, an increase of 28.1%[88]. - Income before income taxes for Asia Pacific Traditional increased to $140 million in Q3 2025, up from $102 million in Q2 2025, representing a 37.3% increase[92]. - The Asia Pacific segment showed a strong performance with total adjusted operating income of $209 million, an increase of $146 million compared to $63 million in the prior year quarter[56]. Notable Items and Adjustments - The notable items impacted adjusted operating income by a reduction of $39 million in Q3 2025, compared to an increase of $53 million in Q3 2024[84]. - Adjusted operating income excluding notable items for U.S. and Latin America Traditional was $97 million in Q3 2025, down from $140 million in Q2 2025, representing a decrease of 30.7%[84]. - Adjusted operating income excluding notable items was $424 million in Q3 2025, compared to $315 million in Q2 2025, and down from $1,176 million year-to-date in 2024[7]. Credit and Securities - The allowance for credit losses for total fixed maturity securities was $161 million as of September 30, 2025, compared to $98 million on December 31, 2024[67]. - The total fixed maturity securities below amortized cost reached $45,788 million as of September 30, 2025, with unrealized losses of $6,512 million[74]. - The total value of corporate fixed maturity securities represented 67.5% of the total fair value as of September 30, 2025[67]. - The total amount of securities rated AAA/AA/A was $63,266 million, accounting for 63.5% of the total fair value as of September 30, 2025[70].
FoxPath Capital Partners Announces Strategic Partnership with Reinsurance Group of America
Businesswire· 2025-10-15 13:11
Core Insights - FoxPath Capital Partners has announced a long-term strategic partnership with RGA, a leading global reinsurer [1] Company Summary - FoxPath Capital Partners is an independent credit secondaries firm [1] - RGA is recognized as a leading global reinsurer [1] Industry Summary - The partnership signifies a strategic move within the insurance and reinsurance sectors, potentially enhancing capabilities in credit secondaries [1]
IIS Announces 2025 RGA Leaders of Tomorrow Finalists: Showcasing the Industry's Rising Stars
Businesswire· 2025-09-25 14:11
Core Points - The International Insurance Society (IIS) has announced the three finalists for the 2025 RGA Leaders of Tomorrow award [1] Group 1 - The award recognizes emerging leaders in the insurance industry [1] - The finalists represent significant contributions to the field of insurance [1] - The announcement highlights the importance of leadership development within the insurance sector [1]